• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine re

tetano

Editor, Senior Moderator
Front Immunol


. 2025 Mar 18:16:1534530.
doi: 10.3389/fimmu.2025.1534530. eCollection 2025. Characterizing HLA-A2-restricted CD8[SUP]+[/SUP] T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients

Chanchan Xiao[SUP] #[/SUP][SUP] 1 2 3 4 5 [/SUP], Jian Xiang[SUP] #[/SUP][SUP] 2 [/SUP], Haoyun Wang[SUP] #[/SUP][SUP] 2 [/SUP], Wen Gao[SUP] #[/SUP][SUP] 2 6 [/SUP], Tianchan Peng[SUP] 7 [/SUP], Shumin Li[SUP] 2 3 [/SUP], Jun Su[SUP] 7 [/SUP], Xi Chen[SUP] 2 [/SUP], Lijuan Gao[SUP] 2 [/SUP], Ruohu Shi[SUP] 2 [/SUP], Xinyi Mou[SUP] 2 [/SUP], Jun Yuan[SUP] 8 [/SUP], Guobing Chen[SUP] 1 2 3 4 [/SUP]



Affiliations
Abstract

Introduction: Recent surveillance has identified the emergence of the SARS-CoV-2 Omicron ariant, which exhibits the ability to evade multiple neutralizing antibodies generated by prior infection or vaccination. However, significant knowledge gaps remain regarding the CD8 T-cell immune reactivity to the Omicron variant. This study aims to evaluate the characteristics of HLA-A2-restricted CD8 T-cell epitopes from the Omicron variant and analyze epitope-specific CD8 T-cell responses to SARS-CoV-2 inactivated vaccines.
Methods: We conducted a comprehensive analysis of CD8 T-cell responses to SARS-CoV-2 inactivated vaccines, focusing on HLA-A2-restricted epitopes derived from the Omicron variant. Mutant epitopes were evaluated for their impact on antigen presentation and CD8 T-cell immune reactivity. Additionally, we screened for epitopes that exhibited reduced CD8 T-cell responses following the emergence of the Omicron variant.
Results: Our findings revealed that mutant epitopes in the Omicron variant led to escape from antigen presentation and diminished CD8 T-cell immune responses. We identified two epitopes associated with decreased CD8 T-cell reactivity post-Omicron variant emergence. Notably, we discovered an S protein epitope, 67A>V, which demonstrated similar proportions of CD8 T-cell specificity between the ancestral and mutant strains, suggesting its conservation and potential immunogenicity for vaccine development. Furthermore, the third dose of the inactivated vaccine significantly increased the number of epitope-specific CD8 T cells, underscoring the importance of booster doses in enhancing cellular immune responses against the Omicron variant.
Discussion: This study highlights the ability of the Omicron variant to evade CD8 T-cell immune responses through epitope mutations, while also identifying conserved epitopes with potential utility in vaccine design. The observed increase in epitope-specific CD8 T cells following a booster dose emphasizes the critical role of additional vaccinations in strengthening cellular immunity against emerging SARS-CoV-2 variants. These findings provide valuable insights for the development of next-generation vaccines targeting conserved epitopes and optimizing booster strategies.

Keywords: CD8 T-cell epitope; Omicron; SARS-CoV-2; cellular immune response; conserved epitope.

 
Back
Top Bottom